Digital Engagement With The Patient
As emerging technologies are integrated into society, the pathway to connect to the patient becomes much shorter. Managing patient symptoms and proactively engage patients for therapeutic options opens up the door for even more discovery and dialogue. See how we create these tools to enable your organization to change what it means for developing ‘patient care’.
Disease & Cancer Genetics
Research and Development
Virtual trial Design / Real-World Evidence
Post Market Surveillance
Digital Research and Life Sciences
Our mission is to ensure that therapeutics and vaccines developed within the life science industry factor in every patient ethnicity and demographics to bolster product efficacy, health equity, and effective patient outcomes.
At Rubix LS, we deliver the data, research, and case management solutions to help life science companies target and address these problems from the onset to ensure that we shorten the gap between delivering highly effective and all-inclusive, product innovations while ensuring inclusivity of all patient populations, equally receive the lifesaving benefits needed in today’s world.
Our focus is simple: Patient Innovation First. Always.
Also supporting the federal markets.
As the world shifts to defend against new emerging health threats, government agencies are grappling with new ways to overcome those challenges. Agile convergence of digital and scientific innovation becomes a crucial vehicle to deliver outcomes-based approaches to achieve mission objectives.
We’re not just innovators, we’re also creating the entrepreneurial structure into agencies that will increase strength and expansion into programs that will catapult science and technology forward.
Latest News & Articles
Recently our Founder and CEO, Reginald Swift, sat down with the team at Pharma Tech Outlook magazine to discuss the changes happening with the pharma industry and how digital health, particularly virtual clinical trials are mobilizing access of pipeline therapeutics...
Health Data in the COVID-19 Crisis: How racial equity is widening for patients to gain access to treatment.
The coronavirus pandemic has placed extraordinary demands on the healthcare industry and the groups that are interconnected with the healthcare industry. The strain on obtaining adequate resources to establish a baseline of trending symptomatic patients and severity...
Rubix LS has joined the federal consortium of industry partners to fully develop plans and strategies for mobilizing robust response measures toward the growing COVID-19 worldwide pandemic in the United States. Rubix LS is joined by countless other firms, within the...